European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: A case-control study in a high UV index region in Brazil

Carregando...
Imagem de Miniatura
Citações na Scopus
32
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Citação
JOURNAL OF DERMATOLOGICAL SCIENCE, v.64, n.1, p.59-66, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: UV radiation is the major environmental factor related to development of cutaneous melanoma. Besides sun exposure and the influence of latitude, some host characteristics such as skin phototype and hair and eye color are also risk factors for melanoma. Polymorphisms in DNA repair genes could be good candidates for susceptibility genes, mainly in geographical regions exposed to high solar radiation. Objective: Evaluate the role of host characteristic.; and DNA repair polymorphism in melanoma risk in Brazil. Methods: We carried out a hospital-based case-control study in Brazil to evaluate the contribution of host factors and polymorphisms in DNA repair to melanoma risk. A total of 412 patients (202 with melanoma and 210 controls) were analyzed regarding host characteristics for melanoma risk as well as for 11 polymorphisms in DNA repair genes. Results: We found an association of host characteristics with melanoma development, such as eye and hair color, fair skin, history of pigmented lesions removed, sunburns in childhood and adolescence, and also European ancestry. Regarding DNA repair gene polymorphisms, we found protection for the XPG 1104 His/His genotype (OR 0.32; 95% CI 0.13-0.75), and increased risk for three polymorphisms in the XPC gene (PAT+; IV-6A and 939Gln), which represent a haplotype for XPC. Melanoma risk was higher in individuals carrying the complete XPC haplotype than each individual polymorphism (OR 3.64; 95% CI 1.77-7.48). Conclusions: Our data indicate that the host factors European ancestry and XPC polymorphisms contributed to melanoma risk in a region exposed to high sun radiation.
Palavras-chave
Melanoma, Case-control, DNA repair gene polymorphisms, XPC, Nucleotide excision repair
Referências
  1. Begg CB, 2006, INT J EPIDEMIOL, V35, P756, DOI 10.1093/ije/dyl044
  2. Wang HT, 2010, P NATL ACAD SCI USA, V107, P12180, DOI 10.1073/pnas.1005244107
  3. Mohrenweiser HW, 2003, MUTAT RES-FUND MOL M, V526, P93, DOI 10.1016/S0027-5107(03)00049-6
  4. Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003
  5. Balch CM, 2001, J CLIN ONCOL, V19, P3622
  6. Correa MD, 2010, PHOTOCHEM PHOTOBIOL, V86, P438, DOI 10.1111/j.1751-1097.2009.00659.x
  7. Perneger TV, 1998, BRIT MED J, V316, P1236
  8. Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166
  9. Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658
  10. Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341
  11. MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215
  12. Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423
  13. de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453
  14. Blankenburg S, 2005, CARCINOGENESIS, V26, P1085, DOI 10.1093/carcin/bgi055
  15. Ou-Yang H, 2004, J INVEST DERMATOL, V122, P492, DOI 10.1046/j.0022-202X.2004.22247.x
  16. Laine JP, 2007, DNA REPAIR, V6, P1264, DOI 10.1016/j.dnarep.2007.02.010
  17. Khan SG, 2002, NUCLEIC ACIDS RES, V30, P3624, DOI 10.1093/nar/gkf469
  18. Povey JE, 2007, CARCINOGENESIS, V28, P1087, DOI 10.1093/carcin/bgl257
  19. Eide MJ, 2005, ARCH DERMATOL, V141, P477, DOI 10.1001/archderm.141.4.477
  20. Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411
  21. Moriwaki S, 2008, J DERMATOL SCI, V50, P169, DOI 10.1016/j.jdermsci.2007.08.011
  22. Li CY, 2006, CANCER EPIDEM BIOMAR, V15, P2526, DOI 10.1158/1055-9965.EPI-06-0672
  23. Baccarelli A, 2004, BRIT J CANCER, V90, P497, DOI 10.1038/sj.bjc.6601385
  24. Millikan RC, 2006, CARCINOGENESIS, V27, P610, DOI 10.1093/carcin/bgi252
  25. Tomescu D, 2001, CARCINOGENESIS, V22, P403, DOI 10.1093/carcin/22.3.403
  26. Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034
  27. Qiao YW, 2002, CARCINOGENESIS, V23, P295, DOI 10.1093/carcin/23.2.295
  28. Han JL, 2005, CANCER EPIDEM BIOMAR, V14, P1539, DOI 10.1158/1055-9965.EPI-04-0846
  29. MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252
  30. BACH CM, 2009, J CLIN ONCOL, V36, P6199
  31. Bakos L, 2009, J EUR ACAD DERMATOL, V23, P304, DOI 10.1111/j.1468-3083.2008.03027.x
  32. Bakos L, 2002, INT J DERMATOL, V41, P557, DOI 10.1046/j.1365-4362.2002.01412.x
  33. Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P520, DOI 10.1111/j.1755-148X.2008.00500.x
  34. Cust AE, 2009, AM J EPIDEMIOL, V170, P1541, DOI 10.1093/aje/kwp307
  35. Ding KY, 2003, BIOINFORMATICS, V19, P2147, DOI 10.1093/bioinformatics/btg276
  36. FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869
  37. Gruber F, 2008, COLLEGIUM ANTROPOL, V32, P147
  38. Hu S, 2004, ARCH DERMATOL, V140, P819, DOI 10.1001/archderm.140.7.819
  39. Loria D, 2001, INT J DERMATOL, V40, P108, DOI 10.1046/j.1365-4362.2001.01132.x
  40. Nijsten T, 2005, J EUR ACAD DERMATOL, V19, P332, DOI 10.1111/j.1468-3083.2005.01196.x
  41. Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010
  42. SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904
  43. SMIT NP, 2001, PHOTOCHEM PHOTOBIOL, V84, P550
  44. Sturm RA, 2009, HUM MOL GENET, V18, P9